OSR Health, Inc.
OSRHOTCCIK 1840425HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1609:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-110051 |
| 2026-10-0216:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-106429 |
| 2026-08-2808:00 ET | 8-K | 8.01 Other events | 0001213900-26-094654 |
| 2026-08-2511:28 ET | 8-K | 8.01 Other events | 0001213900-26-093379 |
| 2026-08-1917:05 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-091756 |
| 2026-08-1415:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-089904 |
| 2026-08-1011:09 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-087087 |
| 2026-08-0715:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-086599 |
| 2026-07-3115:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-083878 |
| 2026-07-1616:36 ET | DEF 14A | Proxy statementPeriod 2026-08-07 | 0001213900-26-078706 |
| 2026-06-1712:27 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-069524 |
| 2026-06-1113:35 ET | 8-K | 8.01 Other events | 0001213900-26-067732 |
| 2026-06-0213:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-064037 |
| 2026-05-2617:00 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001213900-26-061078 |
| 2026-05-1309:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-055492 |
| 2026-05-0617:25 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-052922 |
| 2026-04-3013:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-049967 |
| 2026-04-2217:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-046711 |
| 2026-04-0909:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-041768 |
| 2026-04-0306:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-039691 |
| 2026-04-0215:46 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-039278 |
| 2026-03-3116:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-037395 |
| 2026-03-1608:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001213900-26-027984 |
| 2026-03-1008:01 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-025428 |
| 2026-01-2709:26 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-007987 |
| 2026-01-1409:27 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-004199 |
| 2025-11-2510:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-114496 |
| 2025-11-1214:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109054 |
| 2025-10-1611:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-099393 |
| 2025-09-2308:40 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-090340 |
| 2025-09-0916:47 ET | 8-K | 3.01 Delisting notice | 0001213900-25-086209 |
| 2025-09-0917:39 ET | 8-K | 8.01 Other events | 0001213900-25-085670 |
| 2025-08-2907:00 ET | DEF 14A | Proxy statementPeriod 2025-09-17 | 0001213900-25-082061 |
| 2025-08-2017:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-079053 |
| 2025-08-1414:32 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076461 |
| 2025-08-0608:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-072321 |
| 2025-07-2517:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-067798 |
| 2025-07-0206:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-060679 |
| 2025-06-1016:51 ET | S-1/A | Registration statement, amended | 0001213900-25-053114 |
| 2025-05-2817:23 ET | S-1 | Registration statement | 0001213900-25-048346 |
| 2025-05-2016:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-045947 |
| 2025-05-1216:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-042018 |
| 2025-04-2214:04 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-25-034120 |
| 2025-04-2214:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-034116 |
| 2025-03-2507:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001013762-25-001833 |
| 2025-02-2818:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-018204 |
| 2025-02-2116:10 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001213900-25-016100 |
| 2025-02-1818:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-014490 |
| 2025-02-1316:11 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-013498 |
| 2025-01-2316:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-005957 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:31 ET. Listed shows no prices and gives no investment advice.